Cytokinetics and Fibrocell Science among healthcare gainers; Pulmatrix leads the losers

|About: Bio-Path Holdings, Inc. (BPTH)|By:, SA News Editor

Gainers: Motif Bio (NASDAQ:MTFB) +87%. Nevro (NYSE:NVRO) +34%. Fibrocell Science (NASDAQ:FCSC) +21%. Cytokinetics (NASDAQ:CYTK) +14%. Xencor (NASDAQ:XNCR) +13%.

Losers: Pulmatrix (NASDAQ:PULM) -19%. Bio-Path Holdings (NASDAQ:BPTH) -11%. Vaxart (NASDAQ:VXRT) -10%. Cellectar Biosciences (NASDAQ:CLRB-10%. Soleno Therapeutics (NASDAQ:SLNO-9%.

Subscribe for full text news in your inbox